Journal
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY
Volume 33, Issue 3, Pages 225-227Publisher
ESMON PUBLICIDAD S A, DEPT ALLERGY & CLIN IMMUNOL, CLIN UNIV NAVARRA
DOI: 10.18176/jiaci.0845
Keywords
Systemic mastocytosis; SARS-CoV-2; COVID-19; Malignancy; Treatment